Drug Profile
Tetracycline - Molecular Research Center
Alternative Names: MRC-375Latest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Molecular Research Center
- Class Antibacterials; Skin disorder therapies; Tetracyclines
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 22 Mar 2019 Discontinued - Phase-II for Rheumatoid arthritis in USA (PO)
- 29 Apr 2014 Molecular Research Center completes enrolment in its phase II trial for Rheumatoid arthritis in USA (NCT01408602)